Merck Manual

Please confirm that you are a health care professional

Yes No
honeypot link
Merck Manual
Professional Version
The trusted provider of medical information since 1899
Medical Topics & Chapters
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Professional /
Hematology and Oncology /
Approach to the Patient With Anemia /
... /
Treatment of Anemia /

OTHER TOPICS IN THIS CHAPTER

Approach to the Patient With Anemia
Red Blood Cell Production
Etiology of Anemia
Evaluation of Anemia
Treatment of Anemia

ADDITIONAL CONTENT

Test your knowledge

Overview of Thrombotic Disorders
Thrombotic disorders can be caused by genetic defects, which increase the risk of venous thromboembolism, or acquired defects, which increase the risk of arterial and venous thrombosis. Of the acquired causes, which of the following is most likely to increase a patient’s risk of venous thrombosis?
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID

More Content

Treatment of Anemia

By

Evan M. Braunstein

, MD, PhD, Johns Hopkins University School of Medicine

Last full review/revision Sep 2020| Content last modified Sep 2020
Click here for Patient Education

If identified, the cause of the anemia is treated. When the hemoglobin (Hb) falls dangerously low (eg, < 7 g/dL [< 70 g/L] for patients without cardiopulmonary insufficiency or higher for patients with it), red blood cell (RBC) transfusion temporarily increases oxygen-carrying capacity. RBC transfusion should be reserved for patients

  • With or at high risk of cardiopulmonary symptoms

  • With active, uncontrollable blood loss

  • With some form of hypoxic or ischemic end-organ failure (eg, neurologic ischemic symptoms, angina, tachycardia in patients with underlying heart failure or severe chronic obstructive pulmonary disease)

Transfusion procedures and blood components are discussed elsewhere, as is the evaluation of anemia.

Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
© 2020 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA)
Evaluation of Anemia
Overview of Decreased Erythropoiesis

OTHER TOPICS IN THIS CHAPTER

Approach to the Patient With Anemia
Red Blood Cell Production
Etiology of Anemia
Evaluation of Anemia
Treatment of Anemia
Professionals also read
Anemia of Chronic Disease Anemia of Chronic Disease
Aplastic Anemia Aplastic Anemia
Iron Deficiency Anemia Iron Deficiency Anemia

Test your knowledge

Overview of Thrombotic Disorders
Thrombotic disorders can be caused by genetic defects, which increase the risk of venous thromboembolism, or acquired defects, which increase the risk of arterial and venous thrombosis. Of the acquired causes, which of the following is most likely to increase a patient’s risk of venous thrombosis?
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
 

Also of Interest

 

Merck and the Merck Manuals

Merck & Co., Inc., Kenilworth, NJ, USA is a global healthcare leader working to help the world be well. From developing new therapies that treat and prevent disease to helping people in need, we are committed to improving health and well-being around the world.  The Merck Manual was first published in 1899 as a service to the community.  The legacy of this great resource continues as the Merck Manual in the US and Canada and the MSD Manual outside of North America.  Learn more about our commitment to Global Medical Knowledge.

This icon serves as a link to download the eSSENTIAL Accessibility assistive technology app for individuals with physical disabilities. It is featured as part of our commitment to diversity and inclusion.
View Privacy Shield Verification Status
View APEC CBPR Privacy Certification Status

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:  
verify here.

© 2021 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
TOP